Targeted therapy outcomes in RET-rearranged lung cancers: drug or driver?
Thoracic Oncology Service and Developmental Therapeutics Clinic, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: drilona@mskcc.org.
Alexander
A
Drilon
D000230:Adenocarcinoma; D002289:Carcinoma, Non-Small-Cell Lung; D006801:Humans; D008175:Lung Neoplasms; D051096:Proto-Oncogene Proteins c-ret
D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human